Prabhudas Lilladher is bullish on HDFC Bank has recommended buy rating on the stock with a target price of Rs 1150 in its ...

The Dutchman, seeking a fifth straight crown, was the class of the field all weekend, barely challenged at the front as he ...

Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nilo ...

Abstract: This paper presents a 500 W,13.56 MHz power amplifier, which uses a simple method to combine the output power from two Class-E circuits based on GaN HEMT devices. The output combining ...

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer Series ...

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nilo Therapeutics, a biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched today with a $101 million Series A ...

(MENAFN- GlobeNewsWire - Nasdaq) Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments NEW YORK, Oct. 08, 2025 ...

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, a biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched today with a $101 million Series A ...

Having closed a nine-figure fundraising round, a newly launched biotechnology company hopes to rewire the immune system with drugs aimed at a special kind of nerve cell. Nilo Therapeutics debuted ...